CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-22 | Weiss Lawrence Martin Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −9,378 | 28,136 | ||
| 2021-04-19 | Mallon Mark Chief Executive Officer | Grant or award | +55,736 | 55,736 | ||
| 2021-04-19 | Mallon Mark Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +151,016 | 151,016 | ||
| 2021-03-02 | Brown Douglas Matthew Chief Strategy Officer | Grant or award | +4,655 | 111,644 | ||
| 2021-03-02 | Brown Douglas Matthew Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +26,378 | $53.17 | $1.4M | 26,378 |
| 2021-03-02 | McKenzie Kathryn B Chief Financial Officer | Shares withheld for taxes | −432 | 7,328 | ||
| 2021-03-02 | McKenzie Kathryn B Chief Financial Officer | Grant or award | +6,207 | 13,535 | ||
| 2021-03-02 | McKenzie Kathryn B Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +35,171 | $53.17 | $1.9M | 35,171 |
| 2021-03-02 | VAN OORT DOUGLAS M Chairman and CEO | Shares withheld for taxes | −2,158 | 2,418,293 | ||
| 2021-03-02 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award | +56,423 | 2,474,716 | ||
| 2021-03-02 | Bonello William President, Informatics | Shares withheld for taxes | −432 | 11,128 | ||
| 2021-03-02 | Bonello William President, Informatics | Grant or award | +4,345 | 15,473 | ||
| 2021-03-02 | Bonello William President, Informatics | Grant or award · Stock Option (Right to Buy) | +24,619 | $53.17 | $1.3M | 24,619 |
| 2021-03-02 | BALLIET JENNIFER VP and Chief Culture Officer | Shares withheld for taxes | −173 | 24,595 | ||
| 2021-03-02 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award | +1,862 | 26,457 | ||
| 2021-03-02 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award · Stock Option (Right to Buy) | +10,551 | $53.17 | $561K | 10,551 |
| 2021-03-02 | Pedulla Denise E General Counsel | Shares withheld for taxes | −216 | 56,298 | ||
| 2021-03-02 | Pedulla Denise E General Counsel | Grant or award | +4,345 | 60,643 | ||
| 2021-03-02 | Pedulla Denise E General Counsel | Grant or award · Stock Option (Right to Buy) | +24,619 | $53.17 | $1.3M | 24,619 |
| 2021-03-02 | SHOVLIN ROBERT J. President, Clinical Services | Shares withheld for taxes | −608 | 146,920 |
Page 26 of 51 · 1,005 trades